Corbus Pharmaceuticals I... (CRBP)
NASDAQ: CRBP
· Real-Time Price · USD
7.33
0.12 (1.66%)
At close: May 16, 2025, 3:59 PM
7.65
4.37%
After-hours: May 16, 2025, 07:22 PM EDT
1.66% (1D)
| Bid | 7.1 |
| Market Cap | 89.7M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -50.29M |
| EPS (ttm) | -4.24 |
| PE Ratio (ttm) | -1.73 |
| Forward PE | -1.49 |
| Analyst | Buy |
| Ask | 7.66 |
| Volume | 54,476 |
| Avg. Volume (20D) | 191,967 |
| Open | 7.31 |
| Previous Close | 7.21 |
| Day's Range | 7.21 - 7.39 |
| 52-Week Range | 4.64 - 61.90 |
| Beta | 3.20 |
About CRBP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRBP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRBP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-15.77%
Corbus Pharmaceuticals Holdings shares are trading...
Unlock content with
Pro Subscription
8 months ago
-62.26%
Corbus Pharmaceuticals Holdings shares are trading lower amid sympathy with Novo Nordisk after the company reported results from its Phase2a trial of Monlunabant in obesity. Also, Wedbush maintained an Outperform rating on the stock but lowered its price target from $85 to $51.
